Pharmafile Logo

OTC Awards

- PMLiVE

NHS regional footprints

What to expect from 2019

Not another weight-loss ad

Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?

Page & Page Health

GENERATION Z IS FEARFUL FOR THE FUTURE OF UK HEALTH SERVICES, SAYS NEW REPORT

A comprehensive study into the health attitudes and behaviours of Generation Z shows an overwhelming concern by our youngest voting generation that health services won’t meet their needs or expectations...

Inizio

- PMLiVE

Meet Porterhouse Medical at the ISMPP EU meeting 2019 in London 22 – 23 January

Porterhouse Medical’s strategic publication planning experts are participating in two events at the 2019 European Meeting of the International Society for Medical Publication Professionals, entitled: 'Scientific communications in a fast-paced...

Porterhouse Medical Group

- PMLiVE

UK businesses leaning towards second Brexit vote

Poll comes just ahead of May’s ‘plan B’ Brexit announcement

- PMLiVE

Immunomedics craters after FDA rejects breast cancer ADC

Regulator wants to see more data on manufacturing

China’s clinical trial shake-up

As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location

- PMLiVE

NHS England sees off AbbVie’s Hep C legal challenge

Claims of unfair process dismissed by High Court

Novartis Gehry Building

Novartis forges AI alliance with Oxford University

Part of Novartis drive to become 'data-driven' pharma company

- PMLiVE

Europe closer to biosimilar rule change, despite fierce resistance from pharma

EFPIA says it weakens IP commitment - supporters say it will boost exports

Sanofi reception

FDA adcomm split on Sanofi’s type 1 diabetes drug

Concerns rose after Zynquista-treated patients showed an eight-fold increase in DKA

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?

Healthcare leaders in the European Union should begin preparing for a breakthrough now

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links